SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,038,613 | +31.4% | 8,568 | +24.2% | 0.00% | +200.0% |
Q2 2023 | $790,188 | -94.9% | 6,900 | -93.8% | 0.00% | -96.8% |
Q1 2023 | $15,354,262 | -24.2% | 111,400 | -28.8% | 0.03% | 0.0% |
Q4 2022 | $20,266,312 | +231.0% | 156,400 | +182.3% | 0.03% | +244.4% |
Q3 2022 | $6,123,000 | +227.8% | 55,400 | +122.2% | 0.01% | +800.0% |
Q2 2022 | $1,868,000 | +0.8% | 24,931 | +5.0% | 0.00% | 0.0% |
Q1 2022 | $1,854,000 | -79.8% | 23,739 | -76.7% | 0.00% | -87.5% |
Q4 2021 | $9,193,000 | +38.6% | 102,100 | +42.4% | 0.01% | +100.0% |
Q3 2021 | $6,631,000 | -14.7% | 71,702 | -28.3% | 0.00% | -33.3% |
Q2 2021 | $7,773,000 | +97.3% | 100,000 | +89.2% | 0.01% | +50.0% |
Q1 2021 | $3,939,000 | -33.3% | 52,861 | +52.4% | 0.00% | 0.0% |
Q4 2020 | $5,909,000 | -80.8% | 34,685 | -84.2% | 0.00% | -82.6% |
Q3 2020 | $30,762,000 | +88.7% | 219,311 | +115.4% | 0.02% | +21.1% |
Q2 2020 | $16,304,000 | +374.2% | 101,800 | +190.1% | 0.02% | +280.0% |
Q1 2020 | $3,438,000 | -1.7% | 35,097 | +29.4% | 0.01% | +25.0% |
Q4 2019 | $3,499,000 | +3.7% | 27,115 | -39.5% | 0.00% | +33.3% |
Q3 2019 | $3,374,000 | +68.6% | 44,787 | +240.1% | 0.00% | +50.0% |
Q2 2019 | $2,001,000 | +74.3% | 13,168 | +36.7% | 0.00% | +100.0% |
Q1 2019 | $1,148,000 | -47.4% | 9,635 | -51.8% | 0.00% | -66.7% |
Q4 2018 | $2,183,000 | -32.4% | 20,000 | 0.0% | 0.00% | -25.0% |
Q3 2018 | $3,230,000 | -58.8% | 20,000 | -66.3% | 0.00% | -63.6% |
Q2 2018 | $7,834,000 | +428.6% | 59,267 | +196.3% | 0.01% | +450.0% |
Q1 2018 | $1,482,000 | -21.5% | 20,000 | -41.0% | 0.00% | -33.3% |
Q4 2017 | $1,887,000 | +670.2% | 33,907 | +529.8% | 0.00% | – |
Q3 2017 | $245,000 | -91.8% | 5,384 | -93.9% | 0.00% | -100.0% |
Q2 2017 | $2,990,000 | +931.0% | 88,700 | +803.9% | 0.01% | +500.0% |
Q1 2017 | $290,000 | -97.4% | 9,813 | -97.5% | 0.00% | -95.2% |
Q4 2016 | $10,972,000 | -50.7% | 400,000 | +10.3% | 0.02% | -48.8% |
Q3 2016 | $22,265,000 | +1067.5% | 362,549 | +262.5% | 0.04% | +925.0% |
Q2 2016 | $1,907,000 | +41.2% | 100,000 | +185.7% | 0.00% | +33.3% |
Q4 2015 | $1,351,000 | +20.2% | 35,000 | 0.0% | 0.00% | +50.0% |
Q3 2015 | $1,124,000 | +5.5% | 35,000 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $1,065,000 | – | 35,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,315,000 | $170,397,700 | 13.20% |
EcoR1 Capital, LLC | 2,999,453 | $388,669,120 | 11.83% |
Evolutionary Tree Capital Management, LLC | 63,756 | $8,261,502 | 7.93% |
Tri Locum Partners LP | 119,695 | $15,510,000 | 6.27% |
Avoro Capital Advisors LLC | 3,175,000 | $411,416,500 | 6.15% |
Camber Capital Management LP | 1,250,000 | $161,975 | 5.56% |
Finepoint Capital LP | 131,457 | $17,034 | 5.51% |
ACUTA CAPITAL PARTNERS, LLC | 67,500 | $8,746,650 | 5.38% |
Logos Global Management LP | 220,000 | $28,507,600 | 3.34% |
AFG FIDUCIARY SERVICES LIMITED PARTNERSHIP | 33,454 | $3,401,657 | 3.20% |